Recent Finacing
Recent Raise
Spotlight Therapeutics develops cell-targeted in vivo gene-editing biologics using modular TAGE platform of programmable RNPs to enable direct editing without viral or nanoparticle delivery, advancing oncology and hemoglobinopathy programs.
